The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes

The Performances of Spectral Domain Optical Coherence Tomography for Distinguishing Between Normal Eyes, Glaucoma Suspect and Glaucomatous Eyes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01067482

Acronym

cirrusOCT

Enrollment

Registered

2010-02-11

Start date

2009-09-30

Completion date

2010-03-31

Last updated

2010-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Patient, Glaucoma Suspect Patient, Macular Thickness by Location, Normal Population, RNFL Thickness by Location

Keywords

OCT, spectral domain cirrus, glaucoma, glaucoma suspect, normal population

Brief summary

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Detailed description

Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* BCVA at least 20/60 * refractive error +/- 5 D Or astig +/- 3 D * enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

Exclusion criteria

* VA less than 20/60 * marked RF error * previous ocular trauma or surgery * unreliable visual field * poor signal cirrus OCT (less than 7) * other causes of optic nerve or macular disease other than glaucoma

Countries

Thailand

Outcome results